Psoriatic Arthritis

Read articles about psoriatic arthritis and its management, and its treatment options.


Methotrexate, originally an anti-cancer drug, has been used to treat psoriasis and psoriatic arthritis effectively. This article discusses methotrexate, including side-effects drug interactions, and tests, as well as efficacy in the context of treating psoriatic arthritis.

Psoriatic Arthritis Treatment – The Objective of Therapy

This article discusses the main objectives of psoriatic arthritis treatment and management. Expectations, as well as specific symptoms like joint stiffness are discussed.

Risankizumab in Adults with Psoriatic Arthritis

Explore risankizumab for Psoriatic arthritis: Beyond ACR, it significantly improves enthesitis, dactylitis, and QoL scores like HAQ-DI. Promising in efficacy and safety, with full 208-week study results anticipated for a complete understanding.


Leflunomide was initially developed for use in the treatment of cancer and has been used successfully in rheumatoid arthritis. This article discusses the use of leflunomide for the treatment of psoriatic arthritis.

Biologic Therapy and Risk of Infection

Biologic compounds are being used more frequently to treat a multitude of systemic inflammatory conditions. This article discusses the increased risk of opportunistic infections of tuberculosis, herpes zoster, Legionella pneumophila, and Listeria monocytogenes.

The Role of the Dermatologist in Identification and Treatment of the Early Stages of Psoriatic Arthritis

Early diagnosis of psoriatic arthritis (PsA) is essential for preventing disease progression and joint destruction. We will review the presentation and temporal relationship of psoriasis and PsA, the diagnosis, classification, and management and the role of the dermatologist.

Dermatologic Applications and Safety Considerations of Janus Kinase Inhibitors

Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, represent a new class of medication that have broad potential to treat dermatologic disease.

Apremilast in the Treatment of Psoriasis and Psoriatic Arthritis (Family Practice)

Phosphodiesterase 4 (PDE4) is a key enzyme in the regulation of immune responses of inflammatory diseases through degradation of the second messenger, cyclic adenosine 3',5'-monophosphate (cAMP). Apremilast (APR), a selective PDE4 inhibitor, has been shown to reduce the production of pro-inflammatory cytokines.


Azathioprine is used as an immunosuppressive agent used to control transplant rejection. It is also being used to treat psoriatic arthritis. This article reviews the case for its use for this purpose.

TNF-a Inhibitors in Dermatology

To date, the US FDA has approved three tumor necrosis factor (TNF)-a inhibitors for use in dermatology. The distinct and targeted mechanism of action of the TNF inhibitors allows dermatologists to customize therapy to match the individual needs and characteristics of patients who are candidates for systemic therapy.

Apremilast in the Treatment of Psoriasis and Psoriatic Arthritis

Apremilast, a selective PDE4 inhibitor, has been shown to reduce the production of pro-inflammatory cytokines. A review of clinical trial data treating psoriasis, considering adverse effects, efficacy and tolerance.

Etanercept, a TNF Antagonist for Treatment of Psoriatic Arthritis and Psoriasis

Etanercept (EnbrelĀ®, Amgen and Wyeth), a tumor necrosis factor (TNF) antagonist, was approved in January 2002, for the treatment of psoriatic arthritis (PsA). Etanercept was evaluated for the treatment of PsA and psoriasis in a preliminary study of 60 patients and in a confirmatory phase III study of 205 patients.


Sulfasalazine is the only drug that was developed specifically for arthritis and combines a sulfa drug with acetylsalicylic acid. This article discusses the use of sulfasalazine for treating psoriatic arthritis.

Psoriatic Arthritis – Other Medical Treatments

This article discusses other treatments for psoriatic arthritis that are often used in complement to other treatment modalities like methotrexate. Surgery, physiotherapy, gold, and anti-malarial treatments are all discussed.

Cyclosporin A

Cyclosporin A, originally used as a drug used to fight organ rejection - is used to treat psoriatic arthritis. Its mechanism of action, mode of administration, and side effects are discussed.